MEDP - Medpace Holdings, Inc.

451.2
-15.400   -3.413%

Share volume: 211,507
Last Updated: 03-27-2026
Business Services/Services – Research, Development, Testing Labs: -0.05%

PREVIOUS CLOSE
CHG
CHG%
$466.60
-15.40
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
50%
Profitability 64%
Dept financing 13%
Liquidity 9%
Performance 55%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.25%
1 Month
-1.37%
3 Months
-20.84%
6 Months
-9.90%
1 Year
44.45%
2 Year
11.64%
Key data
Stock price
$451.20
P/E Ratio 
35.07
DAY RANGE
$449.11 - $466.00
EPS 
$15.64
52 WEEK RANGE
$250.05 - $628.92
52 WEEK CHANGE
$48.08
MARKET CAP 
15.821 B
YIELD 
N/A
SHARES OUTSTANDING 
28.381 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
1.38
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$301,268
AVERAGE 30 VOLUME 
$318,835
Company detail
CEO: August J. Troendle
Region: US
Website: medpace.com
Employees: 5,200
IPO year: 2016
Issue type: Common Stock
Market: XNAS
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company was founded in 1992 and is based in Cincinnati, Ohio.

Recent news